• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Delgado-Moreira Juan

    (Last) (First) (Middle)
    C/O HAMILTON LANE INCORPORATED
    110 WASHINGTON STREET, SUITE 1300

    (Street)
    CONSHOHOCKEN PA 19428

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hamilton Lane INC [ HLNE ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    Co-Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    11/11/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 11/11/2024 P 525 A $201.81 21,975 I By Trust(1)
    Class A Common Stock 1,264,816 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Performance Stock (2) (2) (2) Class A Common Stock 544,000 544,000 D
    Explanation of Responses:
    1. These securities are held in trust for the benefit of the reporting person.
    2. Each share of performance stock represents a contingent right to receive one share of Class A common stock. The performance stock vests upon the Issuer's Class A common stock achieving a specified price per share. The performance period of the performance stock ends on September 16, 2031.
    Remarks:
    In addition to serving as an officer and director of the Issuer, the reporting person is a member of a group that beneficially owns more than 10% of the Issuer's Class A common stock.
    /s/ Lauren Platko, attorney-in-fact 11/13/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HLNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    More analyst ratings

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hamilton Lane downgraded by Oppenheimer

      Oppenheimer downgraded Hamilton Lane from Outperform to Perform

      5/15/25 8:08:14 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

      1/21/25 7:49:57 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane downgraded by Goldman with a new price target

      Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

      1/6/25 8:11:18 AM ET
      $HLNE
      Investment Managers
      Finance